Pfizer Inc. (PFE)
Pfizer Inc. is a multinational pharmaceutical company based in New York City. It is one of the largest pharmaceutical companies in the world, with a wide range of products, including prescription drugs, consumer healthcare products, and biologic products. Pfizer is known for its research and development efforts, including the development of the COVID-19 vaccine.
Company Info
US7170811035
717081103
Aug 13, 2012
Highlights
$149.04B
$0.75
35.07
0.20
$45.86B
$29.87B
$15.61B
$24.11 - $31.06
$31.18
1.34%
1.75
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Pfizer Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Pfizer Inc. had a return of -0.87% year-to-date (YTD) and -1.32% in the last 12 months. Over the past 10 years, Pfizer Inc. had an annualized return of 2.42%, while the S&P 500 had an annualized return of 11.36%, indicating that Pfizer Inc. did not perform as well as the benchmark.
PFE
-0.87%
-0.23%
-8.50%
-1.32%
-3.08%
2.42%
^GSPC (Benchmark)
1.96%
1.11%
7.77%
23.90%
12.59%
11.36%
Monthly Returns
The table below presents the monthly returns of PFE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -4.52% | -1.92% | 4.48% | -7.68% | 13.55% | -2.37% | 10.69% | -5.01% | -0.24% | -2.21% | -5.95% | 1.22% | -2.22% |
| 2023 | -13.03% | -8.13% | 0.57% | -4.68% | -1.18% | -3.52% | -0.59% | -1.89% | -6.25% | -7.87% | 1.05% | -5.51% | -41.26% |
| 2022 | -10.09% | -10.91% | 10.29% | -5.22% | 8.97% | -1.15% | -2.91% | -10.45% | -3.25% | 6.38% | 8.61% | 2.21% | -10.41% |
| 2021 | -1.41% | -6.71% | 8.18% | 6.68% | 1.19% | 1.11% | 10.31% | 7.61% | -6.64% | 1.70% | 23.92% | 9.90% | 66.70% |
| 2020 | -3.98% | -10.26% | -2.33% | 17.52% | 0.55% | -14.38% | 18.83% | -1.79% | -2.88% | -3.32% | 15.16% | -3.92% | 3.24% |
| 2019 | -1.90% | 2.12% | -2.03% | -4.38% | 3.15% | 4.34% | -10.34% | -7.61% | 1.07% | 6.79% | 1.36% | 1.71% | -6.90% |
| 2018 | 2.26% | -1.06% | -2.26% | 3.16% | -0.90% | 0.97% | 10.06% | 4.87% | 6.14% | -2.29% | 8.19% | -5.58% | 24.83% |
| 2017 | -2.31% | 8.63% | 0.26% | -0.85% | -2.81% | 2.88% | -1.28% | 3.29% | 5.25% | -1.79% | 4.37% | -0.11% | 15.91% |
| 2016 | -5.55% | -1.71% | -0.10% | 10.36% | 7.04% | 1.47% | 4.77% | -4.88% | -2.67% | -6.38% | 2.37% | 1.06% | 4.43% |
| 2015 | 0.32% | 10.79% | 1.37% | -2.47% | 3.27% | -3.51% | 7.55% | -9.95% | -2.51% | 7.67% | -2.32% | -1.50% | 7.09% |
| 2014 | -0.75% | 6.51% | 0.03% | -2.61% | -4.43% | 0.17% | -2.45% | 2.40% | 0.61% | 1.29% | 4.91% | 0.00% | 5.28% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PFE is 40, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Pfizer Inc. (PFE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Pfizer Inc. provided a 6.39% dividend yield over the last twelve months, with an annual payout of $1.68 per share. The company has been increasing its dividends for 12 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.68 | $1.68 | $1.64 | $1.60 | $1.56 | $1.44 | $1.37 | $1.29 | $1.21 | $1.14 | $1.06 | $0.99 |
Dividend yield | 6.39% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
Monthly Dividends
The table displays the monthly dividend distributions for Pfizer Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | |||||||||||
| 2024 | $0.42 | $0.00 | $0.00 | $0.00 | $0.42 | $0.00 | $0.42 | $0.00 | $0.00 | $0.00 | $0.42 | $0.00 | $1.68 |
| 2023 | $0.41 | $0.00 | $0.00 | $0.00 | $0.41 | $0.00 | $0.41 | $0.00 | $0.00 | $0.00 | $0.41 | $0.00 | $1.64 |
| 2022 | $0.40 | $0.00 | $0.00 | $0.00 | $0.40 | $0.00 | $0.40 | $0.00 | $0.00 | $0.00 | $0.40 | $0.00 | $1.60 |
| 2021 | $0.39 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.39 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $1.56 |
| 2020 | $0.36 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $1.44 |
| 2019 | $0.34 | $0.00 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $1.37 |
| 2018 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $1.29 |
| 2017 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $1.21 |
| 2016 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $1.14 |
| 2015 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $1.06 |
| 2014 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.25 | $0.00 | $0.00 | $0.00 | $0.25 | $0.00 | $0.99 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Pfizer Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Pfizer Inc. was 54.82%, occurring on Apr 25, 2024. The portfolio has not yet recovered.
The current Pfizer Inc. drawdown is 50.82%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -54.82% | Dec 17, 2021 | 591 | Apr 25, 2024 | — | — | — |
| -35.43% | Dec 3, 2018 | 327 | Mar 23, 2020 | 177 | Dec 2, 2020 | 504 |
| -20.46% | Dec 9, 2020 | 54 | Feb 26, 2021 | 103 | Jul 26, 2021 | 157 |
| -19.22% | Aug 2, 2016 | 67 | Nov 3, 2016 | 216 | Sep 14, 2017 | 283 |
| -18.93% | Aug 4, 2015 | 130 | Feb 8, 2016 | 82 | Jun 6, 2016 | 212 |
Volatility
Volatility Chart
The current Pfizer Inc. volatility is 6.51%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Pfizer Inc. compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for PFE in comparison to other companies of the Drug Manufacturers - General industry. Currently, PFE has a PE value of 35.1. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for PFE in comparison to other companies of the Drug Manufacturers - General industry. Currently, PFE has a PEG value of 0.2. This PEG value is considered to be low compared to the rest of the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Pfizer Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |